HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 141 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,689 | +41.2% | 690 | 0.0% | 0.00% | – |
| Q2 2023 | $8,280 | -24.7% | 690 | -18.3% | 0.00% | – |
| Q1 2023 | $11,002 | -70.3% | 845 | -66.3% | 0.00% | – |
| Q4 2022 | $37,024 | +68.3% | 2,505 | +0.4% | 0.00% | – |
| Q3 2022 | $22,000 | -51.1% | 2,495 | -30.4% | 0.00% | – |
| Q2 2022 | $45,000 | -35.7% | 3,587 | -2.7% | 0.00% | – |
| Q1 2022 | $70,000 | +100.0% | 3,687 | +270.9% | 0.00% | – |
| Q4 2021 | $35,000 | -12.5% | 994 | -8.6% | 0.00% | – |
| Q3 2021 | $40,000 | -25.9% | 1,088 | -20.4% | 0.00% | – |
| Q2 2021 | $54,000 | +42.1% | 1,366 | +1.9% | 0.00% | – |
| Q1 2021 | $38,000 | -9.5% | 1,341 | +2.8% | 0.00% | – |
| Q4 2020 | $42,000 | 0.0% | 1,305 | 0.0% | 0.00% | – |
| Q3 2020 | $42,000 | +740.0% | 1,305 | +650.0% | 0.00% | – |
| Q2 2020 | $5,000 | +25.0% | 174 | -21.3% | 0.00% | – |
| Q1 2020 | $4,000 | 0.0% | 221 | +30.8% | 0.00% | – |
| Q4 2019 | $4,000 | – | 169 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERAL ATLANTIC, L.P. | 4,000,000 | $67,760,000 | 1.05% |
| M&G INVESTMENT MANAGEMENT LTD | 7,084,834 | $120,442,178 | 0.54% |
| Bellevue Group AG | 1,802,963 | $30,584,761 | 0.49% |
| AIA Group Ltd | 391,278 | $6,628,249 | 0.32% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 182,052 | $3,083,961 | 0.12% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 4,219,168 | $71,472,706 | 0.11% |
| Hennion & Walsh Asset Management, Inc. | 51,735 | $876,391 | 0.06% |
| Allianz Asset Management GmbH | 1,644,999 | $27,866,283 | 0.05% |
| Janney Capital Management LLC | 17,203 | $291 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 193,811 | $3,268 | 0.01% |